BioSpace News Archive

Collaboration between key players in the pharmaceutical, biotechnology and healthcare fields fortifies responsible business practices and shared value within global health supply chain

“Finish Strong” Tells How to Take Charge of Your End-of-Life Care and Avoid Needless Suffering

Kids and their families will raise awareness of the critical need to advance childhood cancer research

2018 highlights include expansion to U.S., new partnerships with leading pharmaceutical companies, and growth of diagnostic testing portfolio for rare diseases - driving momentum into 2019

The global biotechnology reagents market research report by Technavio predicts the market to post a CAGR of close to 9% during the period 2019-2023

Announced today the launch of a collaboration to discover and develop novel therapies for cardiac disease and diseases associated with cardiac muscle aging.

The ENT surgical devices market witnessed a steady progress and grew at 6.6% y-o-y in 2018.

Over $1 Billion Deployed to Healthcare Transactions in 2018

Pablo J. Cagnoni, M.D., chief executive officer, will present these updates and review 2018 accomplishments today at 9:00 a.m. PT at the 37th Annual J.P. Morgan Healthcare Conference.

• Preparing Three Lead Programs for MLD, ADA-SCID and WAS for Regulatory Filings Over the Next Three Years • Recently Announced Clinical Proof-of-Concept in X-CGD Demonstrates Platform’s Transformative Potential • Advancing Earlier Stage Pipeline with Potential Clinical Proof-of-Concept for TDBT and Clinical Trial Application for MPS-IIIA • Entering 2019 in a Strong Financial Position with $340M in Cash and Investments